Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALG in infants with head lice
NCT00291057Phase 2Terminated
- Start
- Feb 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of malathion in pediculosis capitis. Primary endpoint: Change in cholinesterase level at 1 day. Started Feb 2006; status: terminated.
02
Drugs
malathion
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT00291057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291057.